Shandong Yanggu Huatai Chemical Co., Ltd. Independent Director 2025 Annual Performance Report (Zhu Desheng)
In 2025, as an independent director of Shandong Yanggu Huatai Chemical Co., Ltd. (hereinafter referred to as the "Company"), I have strictly performed my duties in accordance with the requirements of relevant laws, regulations, and rules such as the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," and the "Articles of Association" and the "Work System for Independent Directors." I have faithfully and diligently fulfilled my responsibilities, fully leveraged the independent role of independent directors, and protected the overall interests of the Company and the legitimate rights and interests of all shareholders. The performance in 2025 is hereby reported as follows:
I. Basic Information of Independent Directors
(I) Basic Information
Zhu Desheng, male, born in 1966, Chinese national, with no permanent overseas residency, a member of the Communist Party of China, holds a Ph.D. in Management, is a professor and a certified public accountant. He has served as a lecturer, associate professor, and deputy dean of the School of Accounting at Shandong University of Finance and Economics. He is currently a professor at Shandong University of Finance and Economics and an independent director of Lushan Fortune Da Pharmaceutical Co., Ltd. and Shandong Haihua Co., Ltd. He has served as an independent director of the Company since March 2020.
As my six-year term as an independent director of the Company is about to expire, I have applied to resign from all positions as an independent director and member of the special committees of the sixth board of directors of the Company on March 13, 2026. The resignation application will take effect after the election of new independent directors by the Company's shareholders' meeting. Before the election of new independent directors by the shareholders' meeting, I will continue to perform my duties as an independent director and member of the special committees of the board of directors.
(II) Circumstances That Do Not Affect Independence
I do not hold any positions in Yanggu Huatai other than director. I have no direct or indirect interest relationship with Yanggu Huatai and its major shareholders, nor any other relationship that may affect my independent and objective judgment. I perform my duties independently and am not influenced by Yanggu Huatai or its major shareholders or other entities or individuals.
I have conducted a self-assessment of my independence and confirmed that I meet the independence requirements for serving as an independent director of Yanggu Huatai as stipulated by the applicable regulatory provisions. I have submitted the self-assessment results to the board of directors. The board of directors has evaluated my independence for 2025 and believes that I meet the relevant requirements for independent directors stipulated in the "Administrative Measures for Independent Directors of Listed Companies" and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 2 - Norms for Operation of GEM Listed Companies."
II. Overview of Independent Director's Performance in the Year
During my tenure in 2025, I actively attended the Company's shareholders' meetings, board meetings, and special committee meetings of the board of directors, diligently reviewed all proposals, and expressed independent opinions in accordance with relevant regulations, acting with integrity and diligence.
(I) Attendance at Board Meetings and Shareholders' Meetings
In 2025, the Company held a total of 15 board meetings and 4 shareholders' meetings. I attended all board meetings and shareholders' meetings, with no absences or two consecutive absences without personal attendance. Among these, I attended 14 board meetings via communication. Based on the principles of diligence, pragmatism, integrity, and responsibility, I thoroughly reviewed the proposals submitted to the board of directors and shareholders' meetings for deliberation during the year. I believe that the convening and holding of the Company's board meetings and shareholders' meetings complied with legal procedures and were legal and effective. Therefore, for all proposals submitted for voting at the board meetings in 2025, except for those requiring recusal, I voted in favor, with no dissenting or abstaining votes.